Extracorporeal Membrane Oxygenation for Poisonings Reported to U.S. Poison Centers from 2000 to 2018: An Analysis of the National Poison Data System.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 23 7 2020
pubmed: 23 7 2020
medline: 20 5 2021
Statut: ppublish

Résumé

To assess trends in the use of extracorporeal membrane oxygenation for poisoning in the United States. Retrospective cohort study. The National Poison Data System, the databased owned and managed by the American Association of Poison Control Centers, the organization that supports and accredits all 55 U.S. Poison Centers, 2000-2018. All patients reported to National Poison Data System treated with extracorporeal membrane oxygenation. None. In total, 407 patients met final inclusion criteria (332 adults, 75 children). Median age was 27 years (interquartile range, 15-39 yr); 52.5% were male. Median number of ingested substances was three (interquartile range, 2-4); 51.5% were single-substance exposures. Extracorporeal membrane oxygenation use in poisoned patients in the United States has significantly increased over time (z = 3.18; p = 0.001) in both adults (age > 12 yr) and children (age ≤ 12 yr), increasing by 9-100% per year since 2008. Increase in use occurred more commonly in adults. We found substantial geographical variation in extracorporeal membrane oxygenation use by geospatially mapping the ZIP code associated with the initial call, with large, primarily rural areas of the United States reporting no cases. Overall survival was 70% and did not vary significantly over the study period for children or adults. Patients with metabolic and hematologic poisonings were less likely to survive following extracorporeal membrane oxygenation than those with other poisonings (49% vs 72%; p = 0.004). The use of extracorporeal membrane oxygenation to support critically ill, poisoned patients in the United States is increasing, driven primarily by increased use in patients greater than 12 years old. We observed no trends in survival over time. Mortality was higher when extracorporeal membrane oxygenation was used for metabolic or hematologic poisonings. Large, predominantly rural regions of the United States reported no cases of extracorporeal membrane oxygenation for poisoning. Further research should focus on refining criteria for the use of extracorporeal membrane oxygenation in poisoning.

Identifiants

pubmed: 32697480
doi: 10.1097/CCM.0000000000004401
pii: 00003246-202008000-00003
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1111-1119

Commentaires et corrections

Type : CommentIn

Références

Lippold KM, Jones CM, Olsen EO, et al. Racial/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged ≥18 years in metropolitan areas - United States, 2015-2017. MMWR Morb Mortal Wkly Rep 2019; 68:967–973
Hempstead K, Phillips J. Divergence in recent trends in deaths from intentional and unintentional poisoning. Health Aff (Millwood) 2019; 38:29–35
Gummin DD, Mowry JB, Spyker DA, et al. 2017 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th annual report. Clin Toxicol (Phila) 2018; 56:1213–1415
Levine M, Curry SC, Padilla-Jones A, et al. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: A 25-year experience at a single center. Ann Emerg Med 2013; 62:252–258
Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: A systematic review. J Toxicol Clin Toxicol 2003; 41:595–602
Cole JB, Arens AM, Laes JR, et al. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med 2018; 36:1817–1824
Laes JR, Williams DM, Cole JB. Improvement in hemodynamics after methylene blue administration in drug-induced vasodilatory shock: A case report. J Med Toxicol 2015; 11:460–463
Levine M, Hoffman RS, Lavergne V, et al.; Lipid Emulsion Workgroup: Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol (Phila) 2016; 54:194–221
de Lange DW, Sikma MA, Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol (Phila) 2013; 51:385–393
Keller SP. Management of peripheral venoarterial extracorporeal membrane oxygenation in cardiogenic shock. Crit Care Med 2019; 47:1235–1242
Ramanathan K, Tan CS, Rycus P, et al. Extracorporeal membrane oxygenation for poisoning in adult patients: Outcomes and predictors of mortality. Intensive Care Med 2017; 43:1538–1539
Weiner L, Mazzeffi MA, Hines EQ, et al. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: A retrospective study of the Extracorporeal Life Support Organizations’ ECMO case registry. Clin Toxicol (Phila) 2019 Oct 16. [online ahead of print]
Lewis J, Zarate M, Tran S, et al. The recommendation and use of extracorporeal membrane oxygenation (ECMO) in cases reported to the California Poison Control System. J Med Toxicol 2019; 15:169–177
American Association of Poison Control Centers: National Poison Data System (NPDS): NPDS Coding Users’ Manual© Version 4.1. 2019. Available at: http://bezoar.georgiapoisoncenter.org/wpcontent/uploads/2014/07/NPDS-2019.pdf Accessed January 9, 2020
Daubin C, Lehoux P, Ivascau C, et al. Extracorporeal life support in severe drug intoxication: A retrospective cohort study of seventeen cases. Crit Care 2009; 13:R138
Masson R, Colas V, Parienti JJ, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation 2012; 83:1413–1417
Wang GS, Levitan R, Wiegand TJ, et al.; Toxicology Investigators Consortium: Extracorporeal membrane oxygenation (ECMO) for severe toxicological exposures: Review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol 2016; 12:95–99
Baud F, Lamhaut L, Jouffoy R, et al. [Peripheral circulatory support in acute poisoning: 10 years’ experience]. Emergencias 2016; 28:252–262
Mohan B, Gupta V, Ralhan S, et al. Role of extracorporeal membrane oxygenation in aluminum phosphide poisoning-induced reversible myocardial dysfunction: A novel therapeutic modality. J Emerg Med 2015; 49:651–656
Mohan B, Singh B, Gupta V, et al. Outcome of patients supported by extracorporeal membrane oxygenation for aluminum phosphide poisoning: An observational study. Indian Heart J 2016; 68:295–301
Mohan B, Gupta V, Ralhan S, et al. Impact of extra-corporeal membrane oxygenation on outcome of aluminium phosphide poisoning complicated with myocardial dysfunction. Clin Toxicol 2019; 57:1095–1102
Blum JM, Lynch WR, Coopersmith CM. Clinical and billing review of extracorporeal membrane oxygenation. Chest 2015; 147:1697–1703
Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: A meta-analysis of 1,866 adult patients. Ann Thorac Surg 2014; 97:610–616
DeMartino ES, Braus NA, Sulmasy DP, et al. Decisions to withdraw extracorporeal membrane oxygenation support: Patient characteristics and ethical considerations. Mayo Clin Proc 2019; 94:620–627
Sonntag EA. When clinical advances outpace ethics. AMA J Ethics 2019; 21:375–379
Abrams DC, Prager K, Blinderman CD, et al. Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. Chest 2014; 145:876–882
Brodie D, Vincent JL, Brochard LJ, et al.; International ECMO Network (ECMONet): Research in extracorporeal life support: A call to action. Chest 2018; 153:788–791
Lévy A, Bailey B, Letarte A, et al. Unproven ingestion: An unrecognized bias in toxicological case series. Clin Toxicol (Phila) 2007; 45:946–949
Prosser JM, Smith SW, Rhim ES, et al. Inaccuracy of ECG interpretations reported to the poison center. Ann Emerg Med 2011; 57:122–127
Hoffman RS. Understanding the limitations of retrospective analyses of poison center data. Clin Toxicol (Phila) 2007; 45:943–945

Auteurs

Jon B Cole (JB)

Minnesota Poison Control System, Minneapolis, MN.
Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN.
Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis, MN.
Department of Critical Care Medicine, Abbott Northwestern Hospital, Minneapolis, MN.
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Hennepin Healthcare, Minneapolis, MN.

Travis D Olives (TD)

Minnesota Poison Control System, Minneapolis, MN.
Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN.
Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis, MN.
Department of Critical Care Medicine, Abbott Northwestern Hospital, Minneapolis, MN.
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Hennepin Healthcare, Minneapolis, MN.

Alexandru Ulici (A)

Minnesota Poison Control System, Minneapolis, MN.

John M Litell (JM)

Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN.
Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis, MN.
Department of Critical Care Medicine, Abbott Northwestern Hospital, Minneapolis, MN.

Stacey A Bangh (SA)

Minnesota Poison Control System, Minneapolis, MN.

Ann M Arens (AM)

Minnesota Poison Control System, Minneapolis, MN.
Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN.
Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis, MN.
Department of Critical Care Medicine, Abbott Northwestern Hospital, Minneapolis, MN.
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Hennepin Healthcare, Minneapolis, MN.

Michael A Puskarich (MA)

Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN.
Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis, MN.

Matthew E Prekker (ME)

Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN.
Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis, MN.
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Hennepin Healthcare, Minneapolis, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH